Regression of Left-Ventricular Hypertrophy in Children and Adolescents With Hypertension During Ramipril Monotherapy

American Journal of Hypertension

Volumn 20, Issue 9, 2007, Pages 990-996

  Seeman, Tomáš ^a   Gilík, Jiří ^a   Vondrák, Karel ^a   Šimková, Eva ^a   Flögelová, Hana ^b   Hladíková, Marie ^c   Janda, Jan ^a  

^a UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^b PALACKÝ UNIVERSITY   (Czech Republic)

^c CHARLES UNIVERSITY   (Czech Republic)

Author keywords

children; hypertension; Left ventricular hypertrophy; ramipril; regression

Indexed keywords

RAMIPRIL;

ABDOMINAL PAIN; ADOLESCENT; ARTICLE; CHILD; CHILD HEALTH; CLINICAL ARTICLE; COUGHING; DIASTOLIC BLOOD PRESSURE; DIZZINESS; DRUG DOSE INCREASE; DRUG MECHANISM; ECHOCARDIOGRAPHY; EDEMA; FATIGUE; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERKALEMIA; HYPERTENSION; MALE; MONOTHERAPY; PREVALENCE; PRIORITY JOURNAL; RASH; REMISSION; RENOVASCULAR HYPERTENSION; SIDE EFFECT; STANDING; SYSTOLIC BLOOD PRESSURE;

ADOLESCENT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BODY MASS INDEX; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY; MALE; RAMIPRIL;

EID: 34548285500     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2007.03.009     Document Type: Article

References (34)

1. Brown D.W., Giles W.H., and Croft J.B. Left ventricular hypertrophy as a predictor of coronary heart disease mortality and the effect of hypertension. Am Heart J 140 (2000) 848-856
2. Gosse P. Left ventricular hypertrophy as a predictor of cardiovascular risk. J Hypertens 23 Suppl (2005) S27-S33
3. Muiesan M.L., Salvetti M., Rizzoni D., Castellano M., Donato F., and Agabiti-Rosei E. Association of change in left ventricular mass with prognosis during long-term antihypertensive treatment. J Hypertens 13 (1995) 1091-1105
4. Verdecchia P., Schillaci G., Borgioni C., Ciucci A., Gattobigio R., Zampi I., Reboldi G., and Porcellati C. Prognostic significance of serial changes in left ventricular mass in essential hypertension. Circulation 97 (1998) 48-54
5. Zhang R., Crump J., and Reisin E. Regression of left ventricular hypertrophy is a key goal of hypertension management. Curr Hypertens Rep 5 (2003) 301-308
6. Curry C.L., Robinson H., Brown R., Olivan J., Sami M., Honos G., Ruddy T.D., Balazovjech I., Touzek F., Galinier F., Mariani M., de Cordoue A., Barrandon S., Brault Y., and Guez D. Regression of left ventricular hypertrophy in patients with essential hypertension. Results of 6 month treatment with indapamide. Am J Hypertens 9 (1996) 828-832
7. Ecder T., Edelstein C.L., Chapman A.B., Johnson A.M., Tison L., Gill E.A., Brosnahan G.M., and Schrier R.W. Reversal of left ventricular hypertrophy with angiotensin converting enzyme inhibition in hypertensive patients with autosomal dominant polycystic kidney disease. Nephrol Dial Transplant 14 (1999) 1113-1116
8. Mancia G., Zanchetti A., Agebiti-Rosei E., Benemio G., De Cesaris R., Fogari R., Pessino A., Porcellati C., Salvetti A., Trimarco B., and SAMPLE Study Group. Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression of left ventricular hypertrophy. Circulation 95 (1997) 1464-1470
9. Daniels S.R., Loggie J.M.H., Khoury P., and Kimball T.R. Left ventricular geometry and severe left ventricular hypertrophy in children and adolescents with essential hypertension. Circulation 97 (1998) 1907-1911
10. Belsha C.W., Wells T.G., McNiece K.L., Seib P.M., Plummer J.K., and Berry P.L. Influence of diurnal blood pressure variations on target organ abnormalities in adolescents with mild essential hypertension. Am J Hypertens 11 (1998) 410-417
11. Sorof J., Cardwell G., Franco K., and Portman R. Ambulatory blood pressure and left ventricular mass index in hypertensive children. Hypertension 39 (2002) 903-908
12. Hanevold C., Waller J., Daniels S., Portman R., and Sorof J. The effects of obesity, gender, and ethnic group on left ventricular hypertrophy and geometry in hypertensive children: a collaborative study of the International Pediatric Hypertension Association. Pediatrics 113 (2004) 328-333
13. Ramaswamy P., Lytrivi I.D., Paul C., Golden M., and Kupferman J.C. Regression of left ventricular hypertrophy in children with antihypertensive therapy. Pediatr Nephrol 22 (2007) 141-143
14. Seeman T., Dušek J., Vondrák K., Flögelová H., Geier P., and Janda J. Ramipril in the treatment of hypertension and proteinuria in children with chronic kidney diseases. Am J Hypertens 17 (2004) 415-420
15. Soergel M., Kirschstein M., Busch C., Danne T., Gellermann J., Holl R., Krull F., Reichert H., Reusz G.S., and Rascher W. Oscillometric twenty-four-hour ambulatory blood pressure values in healthy children and adolescents: a multicenter trial including 1141 subjects. J Pediatr 130 (1997) 178-184
16. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents. Update on the 1987 task force report on high blood pressure in children and adolescents. Pediatrics 98 (1996) 649-658
17. Sahn D.J., DeMaria A., Kisslo J., and Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58 (1978) 1072-1083
18. Devereux R.B., Alonso D.R., Lutas E.M., Gottlieb G.J., Campo E., Sachs I., and Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57 (1986) 450-458
19. Daniels S.R., Kimball T.R., Morrison J.A., Khoury P., and Meyer R.A. Indexing left ventricular mass to account for differences in body size in children and adolescents without cardiovascular disease. Am J Cardiol 76 (1995) 699-701
20. De Simone G., Devereux R.B., Daniels S.R., Koren M.J., Meyer R.A., and Laragh J.H. Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol 25 (1995) 1056-1062
21. Hogg R.J., Furth S., Lemley K.V., Portman R., Schwartz G.J., Coresh J., Balk E., Lau J., Levin A., Kausz A.T., Eknoyan G., and Levy A.S. National Kidney Foundation's kidney disease outcomes quality initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification. Pediatrics 111 (2003) 1416-1421
22. Schwartz G.J., Brion L.P., and Spitzer A. The use of plasma creatinine concentration to estimate glomerular filtration rate in infancy, childhood and adolescence. Pediatr Clin North Am 34 (1987) 571-590
23. Bláha P., Vignerová J., Riedlová J., Kobzová J., and Krejčovský L. Sixth all-state anthropology investigation of children and youth 2001. Cesk Slovak Pediatr 58 (2003) 766-770
24. Sharp A., and Mayet J. Regression of left ventricular hypertrophy: hoping for a longer life. J Renin Angio Aldo S 3 (2002) 141-144
25. Agabiti-Rosei E., Muiesan M.L., and Salvetti M. Evaluation of subclinical target organ damage for risk assessment and treatment in the hypertensive patients: left ventricular hypertrophy. J Am Soc Nephrol 17 Suppl (2006) S104-S108
26. Flynn J.T., and Alderman M.H. Characteristics of children with primary hypertension seen at a referral center. Pediatr Nephrol 20 (2005) 961-966
27. Litwin M., Niemirska A., Sladowska J., Antoniewicz J., Daszkowska J., Wierzbicka A., Wawer Z.T., and Grenda R. Left ventricular hypertrophy and arterial wall thickening in children with essential hypertension. Pediatr Nephrol 21 (2006) 811-819
28. Matteucci M.C., Wuhl E., Picca S., Mastrostefano A., Rinelli G., Romano C., Rizzoni G., Mehls O., de Simone G., Schaefer F., and ESCAPE Trial Group. Left ventricular geometry in children with mild to moderate chronic renal insufficiency. J Am Soc Nephrol 17 (2006) 218-226
29. Mitsnefes M.M., Daniels S.R., Schwartz S.M., Meyer R.A., Khoury P., and Strife C.F. Severe left ventricular hypertrophy in pediatric dialysis: prevalence and predictors. Pediatr Nephrol 14 (2000) 898-902
30. Seeman T., Šimková E., Kreisinger J., Vondrák K., Dušek J., Gilík J., Feber J., Dvořák P., and Janda J. Control of hypertension in children after renal transplantation. Pediatr Transplant 10 (2006) 316-322
31. Daniels S.R., Kimball T.R., Morrison J.A., Khoury P., Witt S., and Meyer R.A. Effect of lean body mass, fat mass, blood pressure, and sexual maturation on left ventricular mass in children and adolescents. Statistical, biological, and clinical significance. Circulation 92 (1995) 3249-3254
32. Borzych D., Zurowska A., Balasz I., Sabiniewicz R., and Erecinski J. Left ventricular hypertrophy in paediatric predialysis children and treatment-induced regression of left ventricular mass. Wiad Lek 58 Suppl 1 (2005) 55-57
33. Ulinski T., Genty J., Viau C., Tillous-Borde I., and Deschênes G. Reduction of left ventricular hypertrophy in children undergoing hemodialysis. Pediatr Nephrol 21 (2006) 1171-1178
34. Schmieder R.E. The role of non-haemodynamic factors of the genesis of LVH. Nephrol Dial Transplant 20 (2005) 2610-2612